Prostaglandin E2 alleviates cyclosporin a‐induced bone loss in the rat

Journal of Bone and Mineral Research

Volumn 7, Issue 10, 1992, Pages 1191-1200

  Katz, I A ^a   Jee, W S S ^b   Joffe, I I ^a   Stein, B ^a   Takizawa, M ^a   Jacobs, T W ^a   Setterberg, R ^b   Lin, B Y ^b   Tang, L Y ^b   Ke, H Z ^b   Zeng, Q Q ^b   Berlin, J ^c   Epstein, S ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYCLOSPORIN A; OSTEOCALCIN; PARATHYROID HORMONE; PROSTAGLANDIN E2; CYCLOSPORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; BLOOD; BONE DENSITY; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; IATROGENIC DISEASE; IMAGE PROCESSING; METABOLIC BONE DISEASE; NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RAT STRAIN;

NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER;

ADMINISTRATION, ORAL; ANIMAL; BONE DENSITY; BONE DISEASES, METABOLIC; CALCITRIOL; COMPARATIVE STUDY; CYCLOSPORINE; DINOPROSTONE; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; OSTEOCALCIN; PARATHYROID HORMONES; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026613337     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.5650071011     Document Type: Article

References (50)

1. Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA
2. The mechanism of action of FK 506
3. Inhibition of cytokine production by cyclosporine A and G
4. Growth factors and the regulation of bone remodeling
5. Cyclosporin A in the oophorectomized rat: Unexpected severe bone resorption
6. Cyclosporin‐A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration
7. The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat
8. The role of prostaglandins in the local regulation of bone metabolism
9. 2 on bone formation in cultured fetal rat calvariae: Interaction with cortisol
10. 1 infusion in an infant with congenital heart disease
11. Prostaglandin‐induced hyperostosis. A case report
12. 2 administration
13. 1 in infants with cyanotic congenital heart disease
14. 1 administration
15. 2 in growing rats: Increased metaphyseal hard tissue and cortico‐endosteal bone formation
16. 2 in rapidly growing rats: Depressed longitudinal and radial growth and increased metaphyseal hard tissue mass
17. 2 methyl ester on weanling rat skeleton: Daily and systemic administration
18. 1
19. 2 on vertebral trabecular remodeling in beagles used in a healing study
20. 2 on cancellous and cortical bone in young adult dogs
21. Prostaglandins as an effective antirejection therapy in rat renal allograft recipients
22. The synergistic effect of cyclosporine and iloprost on survival of rat cardiac allografts
23. 2 formation by rat mesangial cells in culture
24. 1 analogue misoprostol in renal‐transplant recipients treated with cyclosporin and prednisone
25. Absence of the vitamin K‐dependent bone protein in fetal rat mineral. Evidence for another γ‐carboxyglutamic acid‐containing component in bone
26. Circulating parathyroid hormone concentrations in normal and vitamin‐D‐deprived rat pups determined with an N‐terminal‐specific radioimmunoassay
27. Ethane‐1‐hydroxyl, 1,1‐diphosphonate (EEHDP) effects on growth and modeling of the rat tibia
28. A quantitative histologic analysis of the growing long bone metaphysis
29. Relationship between surface, volume, and thickness of iliac trabecular bone in aging and osteoporosis: Implications for the microanatomic and cellular mechanisms of bone loss
30. Bone histomorphometry: Standardization of nomenclature, symbols, and units
31. Histomorphometric assay of the growing long bone
32. A method of analysis of trabecular bone dynamics
33. Evidence of sequential remodeling in rat trabecular bone: Morphology, dynamic histomorphometry, and changes during skeletal maturation
34. Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone
35. Cyclosporine‐A induced changes in bone turnover
36. 2 on production of new cancellous bone in the axial skeleton of ovariectomized rats
37. Adult height achieved in children after kidney transplantation
38. 3 in the rat mouse
39. 3 synthesis in rats
40. 2 of renal effects of calcitonin in rats
41. 3‐1‐alpha‐hydroxylase activity in isolated kidney cells of normal and streptozocin‐induced diabetic rats
42. Hypercalcuria with Bartters syndrome: Evidence for an abnormality of vitamin D metabolism
43. Different inhibitory actions of immunomodulating agents and immunosuppressive agents on bone resorption of fetal mouse calvaria
44. Cyclosporine A inhibits calcemic hormone‐induced bone resorption in vitro
45. 2 in the inhibition of osteocalcin synthesis by human osteoblast‐like cells in response to cytokines and systemic hormones
46. 2, plasminogen activator, osteocalcin, and alkaline phosphatase by osteoblast‐like cells derived from human bone
47. Bone histology in renal transplant patients receiving cyclosporin (letter)
48. Bone histology in renal transplant patients receiving cyclosporin (letter)
49. Loss of bone density in heart transplant patients
50. Bone disease in liver transplant recipients: Incidence, timing, and risk factors